Lindsey Walsh
Corneal and Contact Management · Leesburg, FLNPI 1700378163
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,269 of the $1,517 with a category attached, or 83.6%. 14 manufacturers reported payments, led by Johnson & Johnson Surgical Vision, Inc. at 36.0% of the total. Reporting peaked in 2019 at $677 and has fallen 80.0% since, to $136 in 2025.
Across 49 payments — averaging $30.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$545
- Rxsight Inc$223
- Novartis$149
- Biotissue Holdings Inc.$121
- Alcon$111
- AbbVie$74
- plus $294 from 8 others
What the payments were for
- Travel & lodging$24816%
- Food & beverage$1,26984%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 8 | $545 |
| Rxsight Inc | 5 | $223 |
| Novartis | 7 | $149 |
| Biotissue Holdings Inc. | 5 | $121 |
| Alcon | 5 | $111 |
| AbbVie(2 entities) | 4 | $74 |
| Sun Pharmaceutical Industries Inc. | 2 | $53 |
| Aerie Pharmaceuticals, Inc. | 3 | $51 |
| Shire North American Group Inc | 3 | $51 |
| Oyster Point Pharma, Inc. | 2 | $35 |
| Sight Sciences, Inc. | 2 | $35 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $30 |
| Dompe US, Inc. | 1 | $23 |
| Johnson & Johnson Vision Care, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,517 in reported general payments places this provider in the 65th percentile of 67 corneal and contact management providers in Florida.
See all corneal and contact management providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 40 | $48,416 |
| RestasisCyclosporine | 35 | $44,209 |
| LumiganBimatoprost | 21 | $10,508 |
| Cyclosporine | 15 | $7,173 |
| Latanoprost | 323 | $5,921 |
| Brinzolamide | 13 | $2,469 |
| Prednisolone Acetate | 28 | $1,896 |
| Timolol Maleate | 84 | $1,739 |
| Brimonidine Tartrate | 33 | $1,158 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 46 | $881 |
| Dorzolamide Hcl | 20 | $490 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan | $74 | $54,71856 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 67 corneal and contact management providers in Florida.
Other corneal and contact management in Leesburg
- Roxanne Achong-CoanOcoee$171K
- Cory CollierBradenton$35K
- Justine SiergeyOrlando$21K
- Tamara MauleBoca Raton$12K
- Kenneth MallerOakland Park$12K
- Terry van der HeydenNaples$8K
- Brian ArmitageJacksonville$8K
- Gordon PennViera$7K
- Denise Burns LegrosMelbourne$6K
- Jose ArnaoGainesville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.